Ocular Therapeutix (OCUL) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 40.09% |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -38.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.13% |
| Dec 31, 2025 | -32.95% |
| Sep 30, 2025 | -24.05% |
| Jun 30, 2025 | -24.07% |
| Mar 31, 2025 | -26.44% |
| Dec 31, 2024 | -14.87% |
| Sep 30, 2024 | -6.60% |
| Jun 30, 2024 | -3.72% |
| Mar 31, 2024 | 13.47% |
| Dec 31, 2023 | 16.54% |
| Sep 30, 2023 | 11.77% |
| Jun 30, 2023 | 0.72% |
| Mar 31, 2023 | -7.82% |
| Dec 31, 2022 | 4.02% |
| Sep 30, 2022 | 5.08% |
| Jun 30, 2022 | 4.01% |
| Mar 31, 2022 | 18.13% |
| Dec 31, 2021 | 38.51% |
| Sep 30, 2021 | 30.41% |
| Jun 30, 2021 | 25.71% |
| Mar 31, 2021 | 24.22% |
| Dec 31, 2020 | 31.59% |
| Sep 30, 2020 | 35.86% |
| Jun 30, 2020 | 35.41% |
| Mar 31, 2020 | 33.99% |
| Dec 31, 2019 | 26.48% |
| Sep 30, 2019 | 13.53% |
| Jun 30, 2019 | 20.65% |
| Mar 31, 2019 | 8.42% |
| Dec 31, 2018 | -22.43% |
| Sep 30, 2018 | -8.28% |
| Jun 30, 2018 | -7.81% |
| Mar 31, 2018 | -25.26% |
| Dec 31, 2017 | -11.86% |
| Sep 30, 2017 | -23.46% |
| Jun 30, 2017 | -19.20% |
| Mar 31, 2017 | 39.37% |
| Dec 31, 2016 | 7.40% |
| Sep 30, 2016 | 15.97% |
| Jun 30, 2016 | 1.65% |